Details for 2018709132
Up to date per 02.04.2026
Actions
Details for 2018709132
Granted/Registered
European Patent
05.02.2020 A
24.02.2021 B1
29.03.2017
US
201762478506 P
31.07.2017
US
201762539410 P
21.08.2017
US
201762548306 P
05.09.2017
US
201762554538 P
15.09.2017
US
201762559374 P
02.10.2017
US
201762567121 P
26.10.2017
US
201762577655 P
07.11.2017
US
201762582874 P
08.12.2017
US
201762596374 P
C12N 5/0783 20100101AFI20181005BHEP
Owner
Iovance Biotherapeutics, Inc.999 Skyway Road Suite 150 San Carlos, CA 94070US
Representative
No representatives present
Inventor
WARDELL, Seth30204 USF Holly Drive Tampa, FL 33620US
BENDER, James3 Cloverdale Rancho Santa Margarita, CA 92688US
LOTZE, Michael, T.5134 Westminster Place Pittsburgh, PA 15232US
Information about Fees